TRADING UPDATES: LPA to meet consensus; Aptamer raises GBP4.28 million
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 64.50p on 10-04-2026 at 16:00:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 67.00p |
| Sell | 62.00p |
| Last Trade: | Sell 100.00 at 62.00p |
| Day's Volume: | 9,325 |
| Last Close: | 64.50p |
| Open: | 64.50p |
| ISIN: | GB00BMWLM973 |
| Day's Range | 64.50p - 64.50p |
| 52wk Range: | 35.40p - 97.50p |
| Market Capitalisation: | £24.35m |
| VWAP: | 62.84048p |
| Shares in Issue: | 37.76m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Arecor Therape (AREC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 100 | 62.00p | Ordinary |
12:20:54 - 10-Apr-26 |
| Sell* | 8,586 | 62.61p | Ordinary |
10:30:55 - 10-Apr-26 |
| Buy* | 595 | 66.00p | Ordinary |
09:54:52 - 10-Apr-26 |
| Buy* | 100 | 67.00p | Ordinary |
16:14:08 - 09-Apr-26 |
| Buy* | 134 | 67.00p | Ordinary |
15:44:27 - 09-Apr-26 |
| Buy* | 18 | 67.00p | Ordinary |
13:19:26 - 09-Apr-26 |
| Buy* | 12 | 67.00p | SI Trade |
13:19:26 - 09-Apr-26 |
| Unknown* | 10,606 | 66.00p | Ordinary |
08:00:08 - 09-Apr-26 |
| Sell* | 9 | 62.00p | SI Trade |
11:25:28 - 08-Apr-26 |
| Unknown* | 15,000 | 62.50p | Ordinary |
14:48:09 - 07-Apr-26 |
Arecor Therape (AREC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Mar 2026 7:00 am | RNS | Notice of FY25 Results |
| 26th Mar 2026 7:00 am | RNS | Ligand Pharmaceuticals Milestone Payment |
| 9th Mar 2026 7:00 am | RNS-R | Arecor to present at Oppenheimer conference |
| 9th Feb 2026 7:00 am | RNS | 2025 Business Update |
| 6th Jan 2026 2:01 pm | RNS | Fireside Panel Discussion on Diabetes sector |
| 9th Dec 2025 7:00 am | RNS | Arecor and Sequel Med Tech to host fireside panel |
| 17th Nov 2025 11:37 am | RNS | Holding(s) in Company |
| 11th Nov 2025 9:50 am | RNS | Holding(s) in Company |
| 4th Nov 2025 7:00 am | RNS | Enhanced IP Coverage: AT278 & Oral Peptide Program |
| 29th Sep 2025 7:00 am | RNS | Directorate Changes |